Preliminary evidence that monitoring of plasma granulocyte-macrophage colony-stimulating factor may be helpful to differentiate between infection and rejection in renal transplant patients.
Daniel
V
V
Department of Transplantation Immunology, University of Heidelberg, Germany.
Pasker
S
S
Reiss
U
U
Weimer
R
R
Pomer
S
S
Staehler
G
G
Opelz
G
G
D016207:Cytokines / Q000097:blood; D003586:Cytomegalovirus Infections / Q000175:diagnosis / Q000276:immunology; D003937:Diagnosis, Differential; D006084:Graft Rejection / Q000175:diagnosis* / Q000276:immunology; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000097:blood*; D006509:Hepatitis B / Q000175:diagnosis / Q000276:immunology; D006526:Hepatitis C / Q000175:diagnosis / Q000276:immunology; D006561:Herpes Simplex / Q000175:diagnosis / Q000276:immunology; D006801:Humans; D016030:Kidney Transplantation / Q000276:immunology*; D009894:Opportunistic Infections / Q000175:diagnosis* / Q000276:immunology; D011183:Postoperative Complications / Q000175:diagnosis* / Q000276:immunology; D015375:Receptors, Interleukin-2 / Q000032:analysis; D012189:Retrospective Studies
D016207:Cytokines; D015375:Receptors, Interleukin-2; D016178:Granulocyte-Macrophage Colony-Stimulating Factor